Adia Med Inc (ADIA)
| Market Cap | 13.97M +261.0% |
| Revenue (ttm) | 1.17M +10,879.7% |
| Net Income | -277.36K |
| EPS | -0.00 |
| Shares Out | 94.40M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,000 |
| Open | 0.1480 |
| Previous Close | 0.1480 |
| Day's Range | 0.1100 - 0.1489 |
| 52-Week Range | 0.0250 - 0.2777 |
| Beta | -8.77 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Adia Med
Adia Med Inc operates as a clinical-stage regenerative medicine company. The company offers products and services focused on stem cell therapies, regenerative medicine treatments, and clinical research in areas such as aesthetics, orthopedics, and autoimmune diseases. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in ... [Read more]
Financial Performance
In 2025, Adia Med's revenue was $700,508, an increase of 10879.75% compared to the previous year's $6,380. Losses were -$395,464, 118.4% more than in 2024.
Financial StatementsNews
Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million
Winter Park, Florida--(Newsfile Corp. - October 6, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced that it has sold a 30% interest in Adia Labs LLC to Live Oak Health, a stem cell distributor doin...
Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line
New research-use products - Adia30M, AdiaClear, and AdiaEXO - give physicians more options in cell count, format, and concentration for investigational studies. Winter Park, Florida--(Newsfile Corp. -...
Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products
Winter Park, Florida--(Newsfile Corp. - September 22, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and physician-supervised investiga...
Nasdaq Shareholder Requirements Just Verified By Adia Med
Winter Park, Florida--(Newsfile Corp. - September 8, 2026) - Nasdaq requires companies seeking an initial listing on the Nasdaq Capital Market to have a sufficiently broad public shareholder base. Tha...
From Full Sail to Full-Scale: Adia Med Inc. Assembles Intern Social Media Team
Company converts campus session at Full Sail University into an intern-led content team across YouTube, Meta, TikTok, X, and LinkedIn Winter Park, Florida--(Newsfile Corp. - August 31, 2026) - Adia Me...
Adia Med Inc. Engages Lucosky Brookman LLP as Legal Counsel for Planned NASDAQ Uplisting
Winter Park, Florida--(Newsfile Corp. - August 24, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced that it has entered into an engagement letter with Lucosky Brookman LLP ("Lucosky Brookman") to a...
Adia Med Delivers Record Q2 Results: $485K Revenue, First Net Profit, and Nearly Matches Full-Year 2025 Revenue in First Half
Winter Park, Florida--(Newsfile Corp. - August 13, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and advanced clinical services, today...
Adia Med Partners with Full Sail University; CEO Larry Powalisz to Present Company and Explore Student Assistance with SEO, Social Media, and Marketing
Winter Park, Florida--(Newsfile Corp. - August 11, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced a new educational ...
Adia Med to Host Dinner for Physicians at Christner's Steakhouse on August 5 to Discuss Clinical Studies and Collaboration Opportunities
Winter Park, Florida--(Newsfile Corp. - August 5, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced that it will host a...
Adia Med Completes Phase 1 and Formally Launches Phase 2 of Autism Spectrum Disorder Clinical Study
Next Cohort of 30 Children to Begin a New Phase 1 Treatment Group on October 1, 2026, as Successive Enrollment Continues Every Three Months Winter Park, Florida--(Newsfile Corp. - July 29, 2026) - Adi...
Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website
New Platform Now Live, Featuring Expanded Sections on Clinical Studies, Stem Cell Therapies, Aesthetics, Media, Podcasts, Case Studies, and Investor Resources Winter Park, Florida--(Newsfile Corp. - J...
Adia Med's Rise, Highlighting 2.5 Years of Growth Toward NASDAQ
Winter Park, Florida--(Newsfile Corp. - July 13, 2026) - Adia Med Inc. (OTCQB: ADIA) (formerly Adia Nutrition Inc.), focused on regenerative medicine, stem cell therapies, and biologics, today highlig...
Adia Nutrition to Trade as Adia Med Inc. After Lightning-Fast FINRA Review
Name change to appear on Daily List today following expedited review; trading begins tomorrow Winter Park, Florida--(Newsfile Corp. - July 9, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) announced today...
Adia Nutrition Inc. Enters FINRA Home Stretch for Corporate Name Change to Adia Med Inc.
Company Believes All Requirements Satisfied; Approval Expected in the Coming Weeks Winter Park, Florida--(Newsfile Corp. - July 7, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) today announced it has ente...
Adia Med Finds Another Unicorn
CEO Larry Powalisz Spotlights Dr. Lyday, a Leading Stem Cell Champion, in New Podcast. Winter Park, Florida--(Newsfile Corp. - June 30, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine and...
Adia Med Improves Quality of Care with Advanced Ultrasound-Guided IV Training
Dr. Brian Browning to train APRNs and RNs on Butterfly portable ultrasound for more precise, comfortable, and reliable IV therapies Winter Park, Florida--(Newsfile Corp. - June 16, 2026) - Adia Med, t...
Adia Nutrition Inc. Delivers Exciting Update: Name Change to Adia Med Inc. Now Official in Nevada
Winter Park, Florida--(Newsfile Corp. - June 10, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is pleased to confirm that the State of Nevada has officially approved the company's name change to Adia Med ...
Adia Nutrition Launches Dynamic New Subsidiary ADIA Life LLC in Florida to Supercharge Distribution and Unlock a Full Spectrum of Life-Transforming Wellness Solutions
Winter Park, Florida--(Newsfile Corp. - June 8, 2026) - Adia Nutrition (OTCQB: ADIA), a leader in advanced nutrition and regenerative health products, today announced the official launch of its new wh...
Adia Nutrition, Inc. Drops Explosive Sneak Peek of Upcoming Documentary Featuring TNA Wrestling Star Jeff Sciullo (Elias)
Winter Park, Florida--(Newsfile Corp. - June 2, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) is thrilled to announce that the powerful new documentary showcasing TNA Wrestling star and former WWE supers...
Adia Nutrition Announces Expanded Stem Cell Coverage Through Independent Monthly-Membership Health Care Sharing Ministry
Winter Park, Florida--(Newsfile Corp. - May 26, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine and innovative healthcare solutions, today announce...
Adia Med Now Recruiting for Kidney Health and Lower Back Pain Studies Listed on ClinicalTrials.gov
Winter Park, Florida--(Newsfile Corp. - May 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company advancing regenerative medicine, today announced that its subsidiary Adia Med of Wi...
ADIA Nutrition, Inc. Reports Strong Revenue Growth and Operational Momentum for First Quarter 2026
Winter Park, Florida--(Newsfile Corp. - May 15, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced nutrition and regenerative health solutions, today announced its 3rd party reviewed fin...
ADIA Nutrition Announces IRB Approval of All Four Clinical Studies and Registration of Kidney Health Study on ClinicalTrials.gov
Winter Park Autism Study Now Treating Patients; Kidney Study Recruitment to Begin This Week Winter Park, Florida--(Newsfile Corp. - May 11, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a publicly trade...
Adia Nutrition Announces IRB Approval and ClinicalTrials.gov Submission for Groundbreaking Stem Cell Study in Chronic Kidney Disease (CKD)
Winter Park, Florida--(Newsfile Corp. - May 5, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a publicly traded company based in Winter Park, Florida, dedicated to advancing regenerative therapies for ch...
Adia Nutrition Announces Three Pivotal Clinical Studies Receive Major IRB Milestone - Final Approval Now Clearly in Sight
Winter Park, Florida--(Newsfile Corp. - April 28, 2026) - Adia Nutrition, (OTCQB: ADIA) a leader in advanced regenerative health solutions, today announced a major milestone in its clinical research p...